Second-Line Treatment for Advanced Pancreatic Adenocarcinoma: Is There a Role for Gemcitabine?
Daniel M GirardiLuiza Dib B B FariaMarcela C TeixeiraFrederico P CostaPaulo Marcelo G HoffGustavo S FernandesPublished in: Journal of gastrointestinal cancer (2020)
Gemcitabine alone did not show meaningful clinical benefit as second-line treatment after FOLFIRINOX.